75 results
8-K
EX-99.1
VANI
Vivani Medical Inc
26 Mar 24
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
8:31am
of once-yearly administration.
Moving forward, Vivani will focus on developing NPM-115 and its emerging pipeline of innovative miniature, long-term
8-K
EX-99.2
VANI
Vivani Medical Inc
26 Mar 24
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
8:31am
management with the added potential benefit of once - yearly administration. An innovative, biopharmaceutical company developing a portfolio of miniature … adherence Minimally - fluctuating and tunable delivery profiles NanoPortal TM : Innovative Delivery Technology Drug Reservoir Nanotube Membrane 7
8-K
EX-99.1
VANI
Vivani Medical Inc
6 Mar 24
Vivani Medical Appoints Daniel Bradbury to its Board of Directors
8:30am
. (Nasdaq: VANI) (“Vivani” or the “Company”), an innovative, preclinical-stage biopharmaceutical company developing novel, long-term drug implants, today
8-K
EX-99.1
gamjpbti3 aeyco5p3v
5 Mar 24
Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants
4:21pm
424B5
971r24rwdn cshr4312
5 Mar 24
Prospectus supplement for primary offering
11:31am
8-K
EX-99.2
537y8g2 9dwl2wgtlks
28 Feb 24
Regulation FD Disclosure
8:30am
8-K
EX-99.1
vbmls lkuo
28 Feb 24
Regulation FD Disclosure
8:30am
8-K
EX-99.2
tdx6fn54nu9d0f3
14 Nov 23
Results of Operations and Financial Condition
6:06am
8-K
EX-99.1
7ek27htkp77q
14 Nov 23
Results of Operations and Financial Condition
6:06am
8-K
EX-99.1
hid0ra g2r1nus6y
18 Sep 23
Regulation FD Disclosure
6:20am
8-K
EX-99.1
0ai h7s2t3zdeppnr2bk
28 Aug 23
Entry into a Material Definitive Agreement
5:43pm
8-K
EX-99.2
5ol7kg9hm5tk3y49wd
15 May 23
Results of Operations and Financial Condition
6:49am
8-K
EX-99.1
jnle1l4pd9zzg4h1
15 May 23
Results of Operations and Financial Condition
6:49am
DEFR14A
qgdnn7
1 May 23
Revised proxy
4:49pm